The president of Cuba, Miguel Díaz-Canel, today praised the progress of his country in immunizing the population against Covid-19 with the use of vaccine candidates produced by the national biotechnology industry .
Cuba traces its mass vaccination route against Covid-19 In his Twitter account, the president highlighted that, between clinical trials and controlled intervention studies, thousands of Cubans receive the doses of Soberana-02 and Abdala, which paves the way for mass vaccination. ‘Dreaming and continuing a country: This year we will advance in immunization with our vaccines!’ He added.
In another message on the same social network, the head of state thanked those who created and those who produce the island’s immunogens, “because they not only inject our body,” but also sow “security and hope in the national soul.” He also highlighted the song that the Buena Fe group dedicated to this achievement of the science of the Antillean country, and said that, while thousands put their arms out for the rehearsal, there is trust and emotion among the participants. ‘A Cuban sang to celebrate. I see it on the networks and I share it. I put my shoulder.
This is #Cuba #CubaViva ‘, he added. The day before, health authorities of the Caribbean country announced that 70 percent of the Cuban population will be immunized against SARS-Cov-2 between July and August of this year, thanks to a staggered vaccination strategy, which involves different population groups between 19 and 80 years old.
In the Mesa Redonda radio and television program, Ileana Morales, director of Science and Technology of the Ministry of Public Health, explained that the first step for this are the Second phase, III clinical trials that are currently being carried out.
As part of these actions, 44 thousand 10 people will be inoculated with Soberana-02 in Havana, and 48 thousand with Abdala in the eastern part of the country. To this are added two intervention studies to evaluate efficacy in risk groups: the first began in the capital this Monday and will include 150 thousand volunteers, and the second will begin soon and foresees the inclusion of 120 thousand subjects from the provinces of Santiago de Cuba , Granma and Guantánamo (east).
The purpose is to gradually immunize the population, so that between April and May 1.7 million people will be protected against the virus. Later, the research will be extended to other population groups, in a larger trial with both vaccine candidates.
According to the explanation offered, vulnerable groups such as those over 60 will be included in parallel, to reach more than six million immunized people between July and early August.
Source: Prensa Latina
Views: 0
